首页|期刊导航|Cancer Innovation|Annual Review of Systemic Medical Treatment for Colorectal Cancer in 2025

Annual Review of Systemic Medical Treatment for Colorectal Cancer in 2025OA

中文摘要

This review summarizes landmark advances in colorectal cancer treatment in 2025,characterizing the transition to dynamic precision oncology.Immunotherapy has revolutionized mismatch repair-deficient or microsatellite instability-high patients,becoming the standard first-line and perioperative regimen.Precision medicine expanded to patients with BRAF V600E,KRAS mutation,and HER2 amplification.While circulating tumor DNA utility was confirmed for surveillance and guiding rechallenge,its role in real-time treatment adjustment continues to be explored.

Zengzhi Cai;Fan Chen;Ying Jin;Feng Wang

Department of Medical Oncology,Sun Yat-sen University Cancer Center,State Key Laboratory of Oncology in South China,Collaborative Innovation Center for Cancer Medicine,Sun Yat-sen University,Guangzhou,Guangdong,China Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer,Chinese Academy of Medical Sciences,Guangzhou,Guangdong,ChinaDepartment of Medical Oncology,Sun Yat-sen University Cancer Center,State Key Laboratory of Oncology in South China,Collaborative Innovation Center for Cancer Medicine,Sun Yat-sen University,Guangzhou,Guangdong,China Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer,Chinese Academy of Medical Sciences,Guangzhou,Guangdong,ChinaDepartment of Medical Oncology,Sun Yat-sen University Cancer Center,State Key Laboratory of Oncology in South China,Collaborative Innovation Center for Cancer Medicine,Sun Yat-sen University,Guangzhou,Guangdong,China Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer,Chinese Academy of Medical Sciences,Guangzhou,Guangdong,ChinaDepartment of Medical Oncology,Sun Yat-sen University Cancer Center,State Key Laboratory of Oncology in South China,Collaborative Innovation Center for Cancer Medicine,Sun Yat-sen University,Guangzhou,Guangdong,China Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer,Chinese Academy of Medical Sciences,Guangzhou,Guangdong,China

医药卫生

BRAF V600E mutationcirculating tumor DNAcolorectal cancerHER2 amplificationimmunotherapyKRAS G12C mutationmicrosatellite instabilityminimal residual diseaseprecision medicinetargeted therapy

《Cancer Innovation》 2026 (2)

P.60-69,10

National Natural Science Foundation of China,Grant/Award Number:82425048New Cornerstone Science Foundation through the XPLORER PRIZEYoung Talents Program of Sun Yat-sen University Cancer Center,Grant/Award Number:YTP-SYSUCC-0018Changping Laboratory,Grant/Award Number:2025C-12-02Beijing Xisike Clinical Oncology Research Foundation,Grant/Award Number:Y-QL202202-0089。

10.1002/cai2.70057

评论